Regeneron Pharmaceuticals Inc (REGN) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues | 19.23%5,115.80 | 4,290.70 | 3,605.40 | 3,884.30 | 3,754.30 |
2.37%677.80 | 662.10 | 647.70 | - | - | |
| Selling, General, and Administrative | 2.37%677.80 | 662.10 | 647.70 | - | - |
| Research and Development | 10.00%1,794.70 | 1,631.60 | 1,543.50 | - | - |
| Costs And Expenses | 2.35%3,067.60 | 2,997.20 | 2,962.50 | 3,004.40 | 2,727.50 |
| Operating Income/Loss | 58.35%2,048.20 | 1,293.50 | 642.90 | 879.90 | 1,026.80 |
| Nonoperating Income/Loss | 0.68%235.90 | 234.30 | 188.30 | 163.80 | 736.50 |
| Income/Loss From Continuing Operations Before Tax | 49.50%2,284.10 | 1,527.80 | 831.20 | 1,043.70 | 1,763.30 |
| Income Tax Expense/Benefit | 45.26%335.40 | 230.90 | 104.00 | 199.10 | 303.30 |
50.26%1,948.70 | 1,296.90 | 727.20 | 844.60 | 1,460.00 | |
| Attributable To Parent | 50.26%1,948.70 | 1,296.90 | 727.20 | 844.60 | 1,460.00 |
| Basic Average Shares | 1.07%101.70 | 102.80 | 104.00 | -0.50 | 103.60 |
| Diluted Average Shares | 0.38%105.60 | 106.00 | 107.70 | -0.30 | 107.20 |
| Basic Earnings Per Share | 51.82%19.16 | 12.62 | 6.99 | 8.24 | 14.09 |
| Diluted Earnings Per Share | 50.86%18.45 | 12.23 | 6.75 | 7.87 | 13.62 |
| Common Stock Dividends | 0.94 | 0.94 | 0.94 | 0.88 | 0.88 |